Osage University Partners Blog

My Accidental Oncology Thesis October 21, 2012 Martin Lehr
Generally speaking, there are two types of venture capitalists: those that are thesis-driven; and those that are opportunistic. Thesis-driven investors believe that through identification of mar …
Target Selection: How Do VCs Balance Risk? June 14, 2012 Martin Lehr
Target selection is a topic that dominates boardroom discussions for many early stage venture-backed companies. The central question regarding target selection revolves around whether a company …
Where Has All of the Early Stage Capital Gone? March 14, 2012 Martin Lehr
Early stage capital for life science companies is tight at the moment. I believe there are two root causes for the lack of capital: risk aversion among VCs; and the need for VCs to support their …
University Equity Structures in Start-ups January 30, 2012 Martin Lehr
When universities license their technologies to start-ups they often take equity in those start-ups, typically in the form of common stock. The reason why universities take equity can range from …
Welcome Bill Harrington! January 6, 2012 Marc Singer
We are very excited to annouce that Bill Harrington has joined Osage University Partners to focus on life science investments. Bill is a great addition to the Osage family and looks forward to w …